Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/13/26 16:35 | 4/9/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Megna Michael R | O | CHIEF AC | 1 | S | -309 | 46.69 | 0 | -7 | 27 | D | ||||||||||||||||
4/13/26 16:34 | 4/9/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Moat Ross | O | COO | 2 | S.d | -195 | 47.79 | 0 | -4 | 14 | D | ||||||||||||||||
4/8/26 16:43 | 4/6/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Patel Sanj K | DO | CB,CEO | 1 | S.d | -364 | 50.01 | 0 | -7 | 238 | M | ||||||||||||||||
4/8/26 16:34 | 4/6/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Quart Barry D | D | 3 | S.dm | -1,193 | 46.48 | 0 | -26 | 13 | D | |||||||||||||||||
3/4/26 16:40 | 3/2/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Paolini John F. | X0 | O | CHIEF ME | 1 | S.d | -1,793 | 44.82 | 0 | -40 | 61 | D | |||||||||||||||
2/11/26 16:38 | 2/9/26 | KNSA | Health | Drug | Pharmaceutical Preparations | Ragosa Mark | X0 | O | CFO | 1 | S.d | -772 | 43.28 | 0 | -18 | 12 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |